Dosimetric comparison between proton beam therapy, intensity modulated radiation therapy, and 3D conformal therapy for soft tissue extremity sarcoma

References

• Mundt AJ, Awan A, Sibley GS, et al. Conservative surgery and adjuvant radiation therapy in the management of adult soft tissue sarcoma of the extremities: clinical and radiobiological results. Int J Radiat Oncol Biol Phys. 1995;32(4):977–985.
   PubMed Web of Science ®Google Scholar
• Rosenberg SA, Tepper J, Glatstein E, et al. The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg. 1982;196(3):305–315.
   PubMed Web of Science ®Google Scholar
• O'Sullivan B, Davis AM, Turcotte R, et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet. 2002;359(9325):2235–2241.
   PubMed Web of Science ®Google Scholar
• Davis AM, O'Sullivan B, Turcotte R, et al. Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol. 2005;75(1):48–53.
   PubMed Web of Science ®Google Scholar
• Davis AM, O'Sullivan B, Bell RS, et al. Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma. J Clin Oncol. 2002;20(22):4472–4477.
   PubMed Web of Science ®Google Scholar
• Alektiar KM, Brennan MF, Healey JH, et al. Impact of intensity-modulated radiation therapy on local control in primary soft-tissue sarcoma of the extremity. J Clin Oncol. 2008;26(20):3440–3444.
   PubMed Web of Science ®Google Scholar
• Stewart AJ, Lee YK, Saran FH. Comparison of conventional radiotherapy and intensity-modulated radiotherapy for post-operative radiotherapy for primary extremity soft tissue sarcoma. Radiother Oncol. 2009;93(1):125–130.
   PubMed Web of Science ®Google Scholar
• Wang D, Zhang Q, Eisenberg BL, et al. Significant reduction of late toxicities in patients with extremity sarcoma treated with image-guided radiation therapy to a reduced target volume: results of radiation therapy oncology group RTOG-0630 trial. J Clin Oncol. 2015;33(20):2231–2238.
   PubMed Web of Science ®Google Scholar
• Paganetti H. Proton beam therapy. Bristol (UK): IOP Publishing; 2017.
   Google Scholar
• DeLaney TF, Haas RL. Innovative radiotherapy of sarcoma: proton beam radiation. Eur J Cancer. 2016;62:112–123.
   PubMed Web of Science ®Google Scholar
• Keole S, Ashman JB, Daniels TB. Proton therapy for sarcomas. Cancer J. 2014;20(6):409–414.
   PubMed Web of Science ®Google Scholar
• Frisch S, Timmermann B. The evolving role of proton beam therapy for sarcomas. Clin Oncol (R Coll Radiol). 2017;29(8):500–506.
   PubMed Web of Science ®Google Scholar
• Wang D, Bosch W, Roberge D, et al. RTOG sarcoma radiation oncologists reach consensus on gross tumor volume and clinical target volume on computed tomographic images for preoperative radiotherapy of primary soft tissue sarcoma of extremity in radiation therapy oncology group studies. Int J Radiat Oncol Biol Phys. 2011;81(4):e525–e528.
   PubMed Web of Science ®Google Scholar
• Quan EM, Liu W, Wu R, et al. Preliminary evaluation of multifield and single-field optimization for the treatment planning of spot-scanning proton therapy of head and neck cancer. Med Phys. 2013;40(8):081709.
   PubMed Web of Science ®Google Scholar
• Paganetti H. Proton therapy physics - series in medical physics and biomedical engineering. Boca Raton (FL): CRC Press; 2011.
   Google Scholar
• Deng W, Yang Y, Liu C, et al. A critical review of LET-based intensity-modulated proton therapy plan evaluation and optimization for head and neck cancer management. Int J Part Ther. 2021;8(1):36–49.
   PubMedGoogle Scholar
• Laughlin BS, Golafshar MA, Ahmed S, et al. Early experience using proton beam therapy for extremity soft tissue sarcoma: a multicenter study. Int J Part Ther. 2022;9(1):1–11.
   PubMedGoogle Scholar
• Fogliata A, Scorsetti M, Navarria P, et al. Dosimetric comparison between VMAT with different dose calculation algorithms and protons for soft-tissue sarcoma radiotherapy. Acta Oncol. 2013;52(3):545–552.
   PubMed Web of Science ®Google Scholar
• Karasek K, Constine LS, Rosier R. Sarcoma therapy: functional outcome and relationship to treatment parameters. Int J Radiat Oncol Biol Phys. 1992;24(4):651–656.
   PubMed Web of Science ®Google Scholar
• Bishop AJ, Zagars GK, Allen PK, et al. Treatment-related fractures after combined modality therapy for soft tissue sarcomas of the proximal lower extremity: can the risk be mitigated? Pract Radiat Oncol. 2016;6(3):194–200.
   PubMed Web of Science ®Google Scholar
• Dickie CI, Parent AL, Griffin AM, et al. Bone fractures following external beam radiotherapy and limb-preservation surgery for lower extremity soft tissue sarcoma: relationship to irradiated bone length, volume, tumor location and dose. Int J Radiat Oncol Biol Phys. 2009;75(4):1119–1124.
   PubMed Web of Science ®Google Scholar
• Griffin AM, Euler CI, Sharpe MB, et al. Radiation planning comparison for superficial tissue avoidance in radiotherapy for soft tissue sarcoma of the lower extremity. Int J Radiat Oncol Biol Phys. 2007;67(3):847–856.
   PubMed Web of Science ®Google Scholar
• Hong L, Alektiar KM, Hunt M, et al. Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh. Int J Radiat Oncol Biol Phys. 2004;59(3):752–759.
   PubMed Web of Science ®Google Scholar
• Malyapa R, Lowe M, Bolsi A, et al. Evaluation of robustness to setup and range uncertainties for head and neck patients treated with pencil beam scanning proton therapy. Int J Radiat Oncol Biol Phys. 2016;95(1):154–162.
   PubMed Web of Science ®Google Scholar
• Unkelbach J, Bortfeld T, Martin BC, et al. Reducing the sensitivity of IMPT treatment plans to setup errors and range uncertainties via probabilistic treatment planning. Med Phys. 2009;36(1):149–163.
   PubMed Web of Science ®Google Scholar
• Schaffner B, Pedroni E. The precision of proton range calculations in proton radiotherapy treatment planning: experimental verification of the relation between CT-HU and proton stopping power. Phys Med Biol. 1998;43(6):1579–1592.
   PubMed Web of Science ®Google Scholar
• Schneider U, Pedroni E, Lomax A. The calibration of CT hounsfield units for radiotherapy treatment planning. Phys Med Biol. 1996;41(1):111–124.
   PubMed Web of Science ®Google Scholar
• Liu C, Patel SH, Shan J, et al. Robust optimization for intensity modulated proton therapy to redistribute high linear energy transfer from nearby critical organs to tumors in head and neck cancer. Int J Radiat Oncol Biol Phys. 2020;107(1):181–193.
   PubMed Web of Science ®Google Scholar
• Liu W, Zhang X, Li Y, et al. Robust optimization of intensity modulated proton therapy. Med Phys. 2012;39(2):1079–1091.
   PubMed Web of Science ®Google Scholar
• Folkert MR, Singer S, Brennan MF, et al. Comparison of local recurrence with conventional and intensity-modulated radiation therapy for primary soft-tissue sarcomas of the extremity. J Clin Oncol. 2014;32(29):3236–3241.
   PubMed Web of Science ®Google Scholar
• Salerno KE, Alektiar KM, Baldini EH, et al. Radiation therapy for treatment of soft tissue sarcoma in adults: executive summary of an ASTRO clinical practice guideline. Pract Radiat Oncol. 2021;11(5):339–351.
   PubMed Web of Science ®Google Scholar
• Henderson TO, Rajaraman P, Stovall M, et al. Risk factors associated with secondary sarcomas in childhood cancer survivors: a report from the childhood cancer survivor study. Int J Radiat Oncol Biol Phys. 2012;84(1):224–230.
   PubMed Web of Science ®Google Scholar
• Berrington de Gonzalez A, Kutsenko A, Rajaraman P. Sarcoma risk after radiation exposure. Clin Sarcoma Res. 2012;2(1):18.
   PubMedGoogle Scholar
• Chung CS, Yock TI, Nelson K, et al. Incidence of second malignancies among patients treated with proton versus photon radiation. Int J Radiat Oncol Biol Phys. 2013;87(1):46–52.
   PubMed Web of Science ®Google Scholar